Physician profile
Robert J Johnson
NPI 1417467010
$1,299.68
in general payments reported to CMS, 2019-2025
14 companies · $20.05 in 2025
The $20.05 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $899 · 2022: $260 · 2023: $55.01 · 2024: $65.93 · 2025: $20.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $140.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $281.15 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $154.62 | 2021-2024 | Spravato, Invega Sustenna, Invega |
| Otsuka America Pharmaceutical, INC. | $147.59 | 2021-2023 | Rexulti, Abilify Maintena |
| Alkermes, INC. | $129.55 | 2021 | |
| Abbvie INC. | $120.28 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $94.15 | 2021-2023 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $77.83 | 2021-2022 | |
| Acadia Pharmaceuticals INC | $73.13 | 2021-2022 | |
| Lundbeck LLC | $48.72 | 2021-2022 | |
| Almatica Pharma LLC | $41.04 | 2021-2022 | |
| Axsome Therapeutics, INC. | $40.36 | 2022-2025 | Auvelity |
| Eisai INC. | $38.68 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $33.59 | 2021 | |
| Lilly USA, LLC | $18.99 | 2024 | Zepbound, Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.